JP2008500365A - 酸分泌を阻害するために有用な薬学的製剤ならびにその製造方法および使用方法 - Google Patents

酸分泌を阻害するために有用な薬学的製剤ならびにその製造方法および使用方法 Download PDF

Info

Publication number
JP2008500365A
JP2008500365A JP2007515351A JP2007515351A JP2008500365A JP 2008500365 A JP2008500365 A JP 2008500365A JP 2007515351 A JP2007515351 A JP 2007515351A JP 2007515351 A JP2007515351 A JP 2007515351A JP 2008500365 A JP2008500365 A JP 2008500365A
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
proton pump
pump inhibitor
acid
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007515351A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008500365A5 (fr
Inventor
ケイ オルムステッド
ウォレン ホール
ジェラルド ティー． プロール
Original Assignee
サンタラス インコーポレイティッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サンタラス インコーポレイティッド filed Critical サンタラス インコーポレイティッド
Publication of JP2008500365A publication Critical patent/JP2008500365A/ja
Publication of JP2008500365A5 publication Critical patent/JP2008500365A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2007515351A 2004-05-25 2005-05-25 酸分泌を阻害するために有用な薬学的製剤ならびにその製造方法および使用方法 Pending JP2008500365A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57466304P 2004-05-25 2004-05-25
US57464604P 2004-05-25 2004-05-25
PCT/US2005/018585 WO2005115474A1 (fr) 2004-05-25 2005-05-25 Formulations pharmaceutiques utiles pour inhiber la secretion d'acides et procedes correspondants de fabrication et d'utilisation

Publications (2)

Publication Number Publication Date
JP2008500365A true JP2008500365A (ja) 2008-01-10
JP2008500365A5 JP2008500365A5 (fr) 2008-05-08

Family

ID=35450661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007515351A Pending JP2008500365A (ja) 2004-05-25 2005-05-25 酸分泌を阻害するために有用な薬学的製剤ならびにその製造方法および使用方法

Country Status (5)

Country Link
EP (1) EP1750767A4 (fr)
JP (1) JP2008500365A (fr)
CA (1) CA2566655C (fr)
MX (1) MXPA06013585A (fr)
WO (1) WO2005115474A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2012074110A1 (ja) * 2010-12-03 2014-05-19 武田薬品工業株式会社 口腔内崩壊錠
JP2017114833A (ja) * 2015-12-25 2017-06-29 エスエス製薬株式会社 制酸用医薬組成物
KR20210012919A (ko) * 2019-07-26 2021-02-03 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
JP2021507926A (ja) * 2018-01-29 2021-02-25 チョン クン ダン ファーマシューティカル コーポレイション エソメプラゾール及び炭酸水素ナトリウムを含む薬剤学的製剤
JP2021512081A (ja) * 2018-01-29 2021-05-13 チョン クン ダン ファーマシューティカル コーポレイション エソメプラゾール及び炭酸水素ナトリウムを含む安定な薬剤学的組成物
CN112839635A (zh) * 2018-08-23 2021-05-25 株式会社钟根堂 包含埃索美拉唑及碳酸氢钠的具有优秀的释放特性的药剂学制剂
KR20210106857A (ko) * 2020-02-21 2021-08-31 주식회사 종근당 방출특성이 우수한 에스오메프라졸 및 탄산수소나트륨의 약제학적 조성물

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008067037A2 (fr) * 2006-10-05 2008-06-05 Santarus, Inc. Nouvelles formulations pour une libération immédiate d'inhibiteurs de pompe à protons et procédés d'utilisation de ces formulations

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003009846A1 (fr) * 2001-07-09 2003-02-06 Curators Of The University Of Missouri Nouvelles formes posologiques a base de benzimidazole substitue et methode d'utilisation associee
JP2003519656A (ja) * 2000-01-11 2003-06-24 ザ キュレイターズ オブ ザ ユニバーシティーオブ ミズーリ 新規な置換ベンズイミダゾール投与形態およびそれらの使用方法
WO2003061584A2 (fr) * 2002-01-19 2003-07-31 The Curators Of The University Of Missouri Nouvelles formes posologiques de benzimidazole substitue et leur procede d'utilisation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5622719A (en) 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
ATE474559T1 (de) * 2001-06-01 2010-08-15 Pozen Inc Pharmazeutische zusammensetzungen für die koordinierte abgabe von nsaid
CA2531564C (fr) * 2003-07-18 2016-01-19 Santarus, Inc. Formulations pharmaceutiques utilisees pour inhiber une secretion acide et procede de fabrication associe
CA2554271A1 (fr) * 2004-02-10 2005-08-25 Santarus, Inc. Combinaison d'un inhibiteur de la pompe a protons, d'un tampon et d'un medicament anti-inflammatoire non steroidien
CA2561700A1 (fr) * 2004-04-16 2005-12-15 Santarus, Inc. Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003519656A (ja) * 2000-01-11 2003-06-24 ザ キュレイターズ オブ ザ ユニバーシティーオブ ミズーリ 新規な置換ベンズイミダゾール投与形態およびそれらの使用方法
WO2003009846A1 (fr) * 2001-07-09 2003-02-06 Curators Of The University Of Missouri Nouvelles formes posologiques a base de benzimidazole substitue et methode d'utilisation associee
WO2003061584A2 (fr) * 2002-01-19 2003-07-31 The Curators Of The University Of Missouri Nouvelles formes posologiques de benzimidazole substitue et leur procede d'utilisation

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6037840B2 (ja) * 2010-12-03 2016-12-07 武田薬品工業株式会社 口腔内崩壊錠
JPWO2012074110A1 (ja) * 2010-12-03 2014-05-19 武田薬品工業株式会社 口腔内崩壊錠
JP2017114833A (ja) * 2015-12-25 2017-06-29 エスエス製薬株式会社 制酸用医薬組成物
US11759428B2 (en) 2018-01-29 2023-09-19 Chong Kun Dang Pharmaceutical Corp. Pharmaceutical formulation comprising esomeprazole and sodium bicarbonate
US11813285B2 (en) 2018-01-29 2023-11-14 Chong Kun Dang Pharmaceutical Corp. Stable pharmaceutical composition comprising esomeprazole and sodium bicarbonate
JP2021507926A (ja) * 2018-01-29 2021-02-25 チョン クン ダン ファーマシューティカル コーポレイション エソメプラゾール及び炭酸水素ナトリウムを含む薬剤学的製剤
JP2021512081A (ja) * 2018-01-29 2021-05-13 チョン クン ダン ファーマシューティカル コーポレイション エソメプラゾール及び炭酸水素ナトリウムを含む安定な薬剤学的組成物
JP7009634B2 (ja) 2018-01-29 2022-01-25 チョン クン ダン ファーマシューティカル コーポレイション エソメプラゾール及び炭酸水素ナトリウムを含む薬剤学的製剤
JP7003279B2 (ja) 2018-01-29 2022-01-20 チョン クン ダン ファーマシューティカル コーポレイション エソメプラゾール及び炭酸水素ナトリウムを含む安定な薬剤学的組成物
JP2021533177A (ja) * 2018-08-23 2021-12-02 チョン クン ダン ファーマシューティカル コーポレイション エソメプラゾール及び炭酸水素ナトリウムを含む、優れた溶解特性を備えた薬学的製剤
CN112839635A (zh) * 2018-08-23 2021-05-25 株式会社钟根堂 包含埃索美拉唑及碳酸氢钠的具有优秀的释放特性的药剂学制剂
KR102290295B1 (ko) * 2019-07-26 2021-08-17 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
KR20210012919A (ko) * 2019-07-26 2021-02-03 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
KR20210106857A (ko) * 2020-02-21 2021-08-31 주식회사 종근당 방출특성이 우수한 에스오메프라졸 및 탄산수소나트륨의 약제학적 조성물
KR102573842B1 (ko) * 2020-02-21 2023-09-01 주식회사 종근당 방출특성이 우수한 에스오메프라졸 및 탄산수소나트륨의 약제학적 조성물
JP2023515456A (ja) * 2020-02-21 2023-04-13 チョン クン ダン ファーマシューティカル コーポレイション 放出特性に優れたエソメプラゾール及び炭酸水素ナトリウムの薬学的組成物
CN115279348A (zh) * 2020-02-21 2022-11-01 株式会社钟根堂 释放特性优异的埃索美拉唑及碳酸氢钠的药物组合物

Also Published As

Publication number Publication date
EP1750767A4 (fr) 2010-09-22
WO2005115474A1 (fr) 2005-12-08
EP1750767A1 (fr) 2007-02-14
CA2566655A1 (fr) 2005-12-08
MXPA06013585A (es) 2009-07-22
CA2566655C (fr) 2013-04-16
WO2005115474B1 (fr) 2006-02-23

Similar Documents

Publication Publication Date Title
US20220133778A1 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2579177C (fr) Nouvelle formulation de complexe antiacide d'omeprazole a liberation immediate pour inhibition rapide et prolongee de la production d'acide gastrique
EP1718303A2 (fr) Combinaison d'un inhibiteur de la pompe a protons, d'un tampon et d'un medicament anti-inflammatoire non steroidien
US20040248942A1 (en) Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20050239845A1 (en) Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US20050244517A1 (en) Combination of proton pump inhibitor and sleep aid
JP2006528198A (ja) 酸不安定な医薬組成物の即時放出製剤
CA2566655C (fr) Formulations pharmaceutiques utiles pour inhiber la secretion d'acides et procedes correspondants de fabrication et d'utilisation
US20070292498A1 (en) Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
AU2011265561B2 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2005331781B2 (en) Pharmaceutical formulations useful for inhibiting acid secretion
MXPA06005084A (en) Combination of proton pump inhibitor and sleep aid
MXPA06009036A (en) Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
AU2005204242A1 (en) A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080318

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110131

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110428

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110511

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110525

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110706